Literature DB >> 9097072

Astrocyte activation by Sindbis virus: expression of GFAP, cytokines, and adhesion molecules.

C Brodie1, N Weizman, A Katzoff, S Lustig, D Kobiler.   

Abstract

Sindbis virus (SV) is a member of the alphaviruses which has served as a model system for studying viral encephalitis. Although astrocytes are reported to be involved in the pathogenesis of various virus-related diseases, the effects of SV on astrocyte function have not been reported. In this study we compared the effects of two strains of SV, SVA, and SVNI, which differ in their neurovirulent properties, on astrocytes with the use of cultured mouse astrocytes and the rat C6 glial cell line. We found that although both strains can similarly infect and replicate in astrocytes, they induced different changes in the function of these cells. The neurovirulent strain, SVNI, induced a decrease in cell number and a marked increase in the expression of GFAP, whereas SVA did not alter these parameters. In addition, SVNI induced the secretion of the cytokines TNF-alpha and IL-6, the expression of adhesion molecules, and the production of the neurotrophic factor NGF. In contrast, SVA induced smaller increases in the secretion of IL-6 and NGF but did not alter the secretion of TNF-alpha and the expression of the adhesion molecules. Neither virus induced the secretion of IL-2, IL-4, IL-10 and IFN-gamma or the expression of iNOS in the cells. These results indicate that astrocytes, similar to neurons, can serve as target cells to SV infection in the CNS. Moreover, the infection of astrocytes by SVNI leads to changes characteristic of reactive astrogliosis which may contribute to the pathogenesis of SV-induced encephalitis by enhancing the local immune response in the CNS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9097072

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  7 in total

Review 1.  Regulation of inducible nitric oxide synthase gene in glial cells.

Authors:  Ramendra N Saha; Kalipada Pahan
Journal:  Antioxid Redox Signal       Date:  2006 May-Jun       Impact factor: 8.401

2.  Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

Authors:  Atique U Ahmed; Bart Thaci; Nikita G Alexiades; Yu Han; Shuo Qian; Feifei Liu; Irina V Balyasnikova; Ilya Y Ulasov; Karen S Aboody; Maciej S Lesniak
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

3.  Roles of BCL-2 and caspase 3 in the adenosine A3 receptor-induced apoptosis.

Authors:  E Appel; G Kazimirsky; E Ashkenazi; S G Kim; K A Jacobson; C Brodie
Journal:  J Mol Neurosci       Date:  2001-12       Impact factor: 3.444

4.  CpG Oligonucleotides Protect Mice From Alphavirus Encephalitis: Role of NK Cells, Interferons, and TNF.

Authors:  Mohanraj Manangeeswaran; Aaron P Lewkowicz; Tomer Israely; Derek D C Ireland; Daniela Verthelyi
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561

5.  Induction of cytopathogenicity in human glioblastoma cells by chikungunya virus.

Authors:  Rachy Abraham; Prashant Mudaliar; Aiswaria Padmanabhan; Easwaran Sreekumar
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

6.  Innate immune response in neuronopathic forms of Gaucher disease confers resistance against viral-induced encephalitis.

Authors:  Sharon Melamed; Roy Avraham; Deborah E Rothbard; Noam Erez; Tomer Israely; Ziv Klausner; Anthony H Futerman; Nir Paran; Einat B Vitner
Journal:  Acta Neuropathol Commun       Date:  2020-08-24       Impact factor: 7.801

7.  Lung pathology due to hRSV infection impairs blood-brain barrier permeability enabling astrocyte infection and a long-lasting inflammation in the CNS.

Authors:  Karen Bohmwald; Jorge A Soto; Catalina Andrade-Parra; Ayleen Fernández-Fierro; Janyra A Espinoza; Mariana Ríos; Eliseo A Eugenin; Pablo A González; María Cecilia Opazo; Claudia A Riedel; Alexis M Kalergis
Journal:  Brain Behav Immun       Date:  2020-09-24       Impact factor: 7.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.